A new UK spin-out dedicated to the technology of DNA repair has received £6 million in Series A funding from a venture capital syndicate led by Sofinnova Partners. The technology comes from the laboratory of Prof Stephen Jackson. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
